Company / Cost of Revenue
Enovis Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$902.8M
FY2025
5-year range
$517.1M / $926.9M
FY2021-FY2025
Trend
-2.6%
vs FY2024
Sector context
#51 of 113
Health Care
What the data says
At $903M, Enovis's cost of revenue ranks #63 of 113 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $517M in FY2022 to $2.4B in FY2017.
Based on SEC 10-K filings.
$903M in FY2025 with a 5-year CAGR of -9.2%.
Increased from $649M to $903M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +20.4%
- 5-Year CAGR
- -9.2%
- 10-Year CAGR
- -
Sector benchmark
#63 of 113 in Health CareTop 55% of 113This company $902.8M Sector average $11.3B
▼
-92.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.2%, indicating a declining trend.
- In FY2025, cost of revenue decreased 2.6% year-over-year.
- Ranks #51 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $902.8M | -2.6% |
| FY2024 | $926.9M | +42.9% |
| FY2023 | $648.5M | +25.4% |
| FY2022 | $517.1M | -20.3% |
| FY2021 | $648.5M | -55.7% |
| FY2020 | $1.5B | +15.6% |
| FY2019 | $1.3B | -13.5% |
| FY2018 | $1.5B | -38.0% |
| FY2017 | $2.4B | +7.7% |
| FY2016 | $2.2B | -24.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026